Atlas Trials

Clofarabine in Chinese Pediatric Patients With Refractory or Relapsed Acute Lymphoblastic Leukemia

Clinical trial NCT02544789 · COMPLETED

Trial details

NCT number
NCT02544789
Sponsor
Betta Pharmaceuticals Co., Ltd.
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Acute Lymphoblastic Leukemia
Start date
2009-06-01
Primary completion
2011-11-01
Enrollment
44

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.